QQQ   431.58 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.32 (-1.84%)
T   16.03 (-1.29%)
F   12.08 (-1.23%)
MU   121.01 (-0.30%)
GE   154.82 (+0.73%)
CGC   7.00 (+0.29%)
DIS   114.09 (+1.01%)
AMC   2.72 (+10.12%)
PFE   25.86 (-0.19%)
PYPL   63.83 (+0.50%)
XOM   118.80 (-0.74%)
QQQ   431.58 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.32 (-1.84%)
T   16.03 (-1.29%)
F   12.08 (-1.23%)
MU   121.01 (-0.30%)
GE   154.82 (+0.73%)
CGC   7.00 (+0.29%)
DIS   114.09 (+1.01%)
AMC   2.72 (+10.12%)
PFE   25.86 (-0.19%)
PYPL   63.83 (+0.50%)
XOM   118.80 (-0.74%)
QQQ   431.58 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.32 (-1.84%)
T   16.03 (-1.29%)
F   12.08 (-1.23%)
MU   121.01 (-0.30%)
GE   154.82 (+0.73%)
CGC   7.00 (+0.29%)
DIS   114.09 (+1.01%)
AMC   2.72 (+10.12%)
PFE   25.86 (-0.19%)
PYPL   63.83 (+0.50%)
XOM   118.80 (-0.74%)
QQQ   431.58 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.32 (-1.84%)
T   16.03 (-1.29%)
F   12.08 (-1.23%)
MU   121.01 (-0.30%)
GE   154.82 (+0.73%)
CGC   7.00 (+0.29%)
DIS   114.09 (+1.01%)
AMC   2.72 (+10.12%)
PFE   25.86 (-0.19%)
PYPL   63.83 (+0.50%)
XOM   118.80 (-0.74%)
Free Trial

CureVac (CVAC) Stock Forecast & Price Target

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)
Free CVAC Stock Alerts
$2.69
+0.04 (+1.51%)
(As of 11:50 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

CureVac Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$15.00
457.62% Upside
High Forecast$24.00
Average Forecast$15.00
Low Forecast$8.00
TypeCurrent Forecast
4/17/23 to 4/16/24		1 Month Ago
3/18/23 to 3/17/24		3 Months Ago
1/17/23 to 1/17/24		1 Year Ago
4/17/22 to 4/17/23
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$15.00$15.00$15.75$24.33
Predicted Upside457.62% Upside68.35% Upside73.59% Upside180.55% Upside
Get CureVac Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter.

CVAC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CVAC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CureVac Stock vs. The Competition

TypeCureVacMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside466.04% Upside882.30% Upside11.22% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/5/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingNeutral
8/21/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetUnderperform ➝ Underperform$10.00 ➝ $8.00-8.36%
6/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$13.00+31.05%
4/26/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$34.00 ➝ $24.00+231.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:09 PM ET.

CVAC Price Target - Frequently Asked Questions

What is CureVac's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for CureVac stock is Hold based on the current 1 sell rating, 1 hold rating and 1 buy rating for CVAC. The average twelve-month price prediction for CureVac is $15.00 with a high price target of $24.00 and a low price target of $8.00. Learn more on CVAC's analyst rating history.

Do Wall Street analysts like CureVac more than its competitors?

Analysts like CureVac less than other Medical companies. The consensus rating for CureVac is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how CVAC compares to other companies.

Does CureVac's stock price have much upside?

According to analysts, CureVac's stock has a predicted upside of 68.35% based on their 12-month stock forecasts.

What analysts cover CureVac?

CureVac has been rated by Guggenheim in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:CVAC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency